Buying into a good company won't mean much if you pay too much. I employ a buy-and-hold approach, but I often ask myself if I can get shares at a better value.
There have been two pops of at least 20% for industrial biotech in the last week -- both on the heels of expected news, nonetheless. Last week Codexis, Inc.
In the financial world, there are tons of methods investors can use to analyze their holdings. Some of the most under-the-radar are hedge fund and insider trading activity.
Until costs drop below those of alternatives, you want to be on the buy side of the transaction. You want to be creating a market, not producing product.
At the end of 2012, renewable-oils manufacturer Solazyme Inc (NASDAQ:SZYM) announced that it had performed two upstream process runs in 500,000-liter fermenters.